Table 3.
Analysis of clinical predictive factors.
| Clinical predictive factors for response | |||
| Tumor control (SD, CR, PR) | Brain progression (PD) | P value | |
| Lung Cancer | 16 | 7 | 0.363 |
| All the others | 29 | 7 | |
| Males | 25 | 7 | 0.321 |
| Females | 17 | 10 | |
| KPS <70 | 6 | 10 | < 0.0001 |
| KPS ≥70 | 29 | 4 | |
| No previous chemotherapy | 20 | 5 | 0.758 |
| Previous chemotherapy | 25 | 9 | |
| No extracranial disease | 25 | 2 | 0.012 |
| Extracranial disease | 20 | 12 | |
| Age > 65 years | 6 | 10 | <0.0001 |
| Age ≤65 years | 39 | 4 | |
| RPA as a predictive factor for response | |||
| Tumor control (SD, CR, PR) | Brain progression (PD) | P value | |
| RPA 1 | 14 | 0 | < 0.0001 |
| RPA 2 | 25 | 4 | |
| RPA 3 | 6 | 10 | |